X T L Biopharmaceuticals reported $5.44M in Equity Capital and Reserves for its fiscal quarter ending in December of 2024.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Bioline Rx USD 19.53M 537K Sep/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025
X T L Biopharmaceuticals USD 5.44M 282K Dec/2024